HealthExtras Named Again to Fortune's "100 Fastest Growing Companies" List

  
    
  
  
    
      HealthExtras, Inc. (NASDAQ:HLEX) announced today that for the second 
      time in four years it was named on Fortune Magazine’s 
      “100 Fastest Growing Companies” 
      List. The Company ranked No. 3 among growing Health Care Companies, 
      No.16 for Sales growth and No. 70 for overall growth in 2008.
    
    
      “Clearly, we are pleased to be recognized as 
      one of Fortune’s 100 Fastest Growing Companies 
      for 2008," said David T. Blair, Chief Executive Officer of HealthExtras. “We 
      have experienced significant growth through our pharmacy benefit 
      management subsidiary Catalyst Rx.” As 
      previously announced, HealthExtras will change its name to Catalyst 
      Health Solutions, Inc., effective on October 1, 2008, and the Company 
      will trade under the ticker symbol “CHSI.” 
      Catalyst Rx accounted for substantially all of the total corporate 
      revenue for the year ended December 31, 2007.
    
    
      Companies that qualify for the 100 Fastest Growing Companies list must 
      be incorporated in the U.S.; have a minimum market capitalization of 
      $250 million on June 30, 2008; have a stock price of at least $5; have 
      been trading continuously since June 30, 2005; have revenue and net 
      income for the four quarters ended on or before June 30, 2008, of at 
      least $50 million and $10 million, respectively; and have posted a 
      compound annual growth in revenue and earnings per share of at least 25% 
      annually over the three years ended on or before June 30, 2008. All 
      companies that meet those criteria are ranked by their revenue growth 
      rate, their EPS growth rate, and their three-year annualized total 
      return to investors for the period ended June 30, 2008. The overall rank 
      is based on the sum of the three ranks.
    
    
      About HealthExtras, Inc. (Note: 
      Becomes Catalyst Health Solutions, Inc., effective October 1, 2008, 
      under new NASDAQ trade symbol “CHSI”)
    
    
      HealthExtras, Inc. is built on strong, innovative principles in the 
      management of prescription drug benefits and provides an unbiased, 
      client-centered philosophy resulting in a year-over-year client 
      retention rate of more than 98%. The Company's subsidiaries include 
      Catalyst Rx, a full-service pharmacy benefit manager serving more than 
      five million lives in the United States and Puerto Rico; HospiScript 
      Services, LLC, one of the largest providers of pharmacy benefit 
      management services to the hospice industry; and Immediate 
      Pharmaceutical Services, Inc., a fully-integrated prescription mail 
      service facility based out of Avon Lake, Ohio. The Company's clients 
      include self-insured employers including state and local governments, 
      managed care organizations, unions, hospices, third-party administrators 
      and individuals.
    
    
      This press release may contain forward-looking statements within the 
      meaning of Section 21E of the Securities Exchange Act of 1934. These 
      forward-looking statements involve a number of risks and uncertainties. 
      Factors that we have identified that might materially affect our results 
      are discussed in our Annual Report on Form 10-K for the year ended 
      December 31, 2007, under "Item 1.A Risk Factors." Readers are urged to 
      carefully review and consider the various disclosures made in our Annual 
      Report on Form 10-K and our other filings with the Securities and 
      Exchange Commission that attempt to advise interested parties of the 
      risks and uncertainties that may affect our business.